BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18583268)

  • 1. [Changes of plasma high-sensitive C-reactive protein and monocyte chemotactic factor-1 following percutaneous coronary interventional procedures in patients with coronary artery disease].
    Wang SL; Han YL; Liu LJ; Yan CH; Kang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1073-5. PubMed ID: 18583268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
    Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
    Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
    Mohan V; Deepa R; Velmurugan K; Premalatha G
    Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
    Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
    Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
    Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
    Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V
    Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
    Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
    Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment.
    Garg R; Tellez A; Alviar C; Granada J; Kleiman NS; Lev EI
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):205-9. PubMed ID: 18651648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
    Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
    Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
    Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
    Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
    Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
    Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
    Huang W; Chen QW; Lei H; Deng W; Ke DZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.